शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans

This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →

MAXHEALTHBSEMAX HEALTHCARE INS LTD· Healthcare ServicesHighPositive
Announced Fri, 30 Oct, 2026 · 14:52 IST

Max Healthcare Q2 revenue rises 20% to Rs 3,219 crore; PAT up 10% to Rs 448 crore

Revenue growth above 20%Results View source PDFExplain this filing

MAXHEALTH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.8%Reaction day
₹853.00
prior close
₹865.60
announcement price
In-mkt
timing
Nifty 100market+0.3%+0.5% vs market
Hospital peers, median of 25sector-0.1%+0.9% vs sector

On the reaction day the stock moved 0.5 pts more than Nifty 100 and 0.9 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.5
10m
+0.1
15m
+0.3
30m
+0.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.8+0.3+0.5-0.1+0.9
Next day
+3.5+2.0+1.4-0.2+3.6
2d
+4.6+3.5+1.1+1.5+3.2
3d
+8.2+4.4+3.8+4.5+3.7
4d
+9.3+6.7+2.6+5.3+3.9
5d
+9.5pendingpending+4.7+4.8
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty 100Sector · Hospital peers, median of 25Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Max Healthcare reported unaudited Q2 FY27 network gross revenue of Rs 3,219 crore, up 20% year on year, and PAT of Rs 448 crore, up 10% after adjusting for a prior-year one-time tax gain. Operating EBITDA rose 18% to Rs 820 crore; margin was nearly flat at 26.8%. Occupancy was 77%, beds rose 16% to 5,518, and net debt was Rs 2,369 crore.

Likely market impact

Strong revenue growth supports the stock, but PAT grew slower than sales and PAT margin fell to 14.7% from 15.7%, keeping the outlook balanced.

By the numbersConsolidated · Q2 FY27 vs Q2 FY26
Q2 FY27Q2 FY26Change
Revenue₹2,569 Cr₹2,135 Cr+20.3%
Operating profit₹500.0 Cr₹413.1 Cr+21.0%
Profit after tax₹414.5 Cr₹491.3 Cr−15.6%
EBITDA margin27.7%26.9%+0.8 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.